Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 05, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-20-000028.pdf 0001804220-20-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 05, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-20-000030.pdf 0001804220-20-000030.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 03, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000046.pdf 0001237899-20-000046.xls
Oct 23, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000044.pdf 0001237899-20-000044.xls
Oct 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000042.pdf 0001237899-20-000042.xls
Oct 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000043.pdf 0001237899-20-000043.xls
Oct 05, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000041.pdf 0001237899-20-000041.xls
Sep 23, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000106.pdf 0001708138-20-000106.xls
Sep 23, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000105.pdf 0001708138-20-000105.xls
Sep 03, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000040.pdf 0001237899-20-000040.xls

Data provided by Kaleidoscope.

Investors & Media